Rayonier: Q2 Earnings Insights

Rayonier (NYSE:RYN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:12 PM. Here's what investors need to know about the announcement. Earnings Rayonier beat estimated earnings by 6.67%, reporting an EPS of $0.16 versus an estimate of $0.15.

Rayonier (NYSE:RYN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:12 PM.

Here’s what investors need to know about the announcement.

Earnings

Rayonier beat estimated earnings by 6.67%, reporting an EPS of $0.16 versus an estimate of $0.15.

Revenue was down $45.10 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 6.71% drop in the share price the next day.

Here’s a look at Rayonier’s past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.16 0.14 0.09
EPS Actual 0.20 0.01 0.35 0.22
Revenue Estimate 228.87M 204.15M 236.34M 211.33M
Revenue Actual 222.00M 262.00M 364.70M 291.40M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Rayonier management provided guidance for FY 2022, expecting earnings between $0.57 and $0.63 per share.

To track all earnings releases for Rayonier visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Investor Sentiment Declines Ahead Of Fed Minutes

The CNN Money Fear and Greed index showed some decline in overall sentiment among U.S. investors on Monday. U.S. stocks closed slightly higher on Monday in a shortened trading session, after the Nasdaq Composite recorded the best first half since 1983. U.S. stock markets closed early ahead of the Fourth of July holiday on Monday and also remained closed on Tuesday.

TSLA

Read More

$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO’s Q2 2023

Societal CDMO Inc. (NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for small molecule therapeutics, reported financial results for the three and six months ended June 30, 2023.

SCTL

Read More

Female-Led California Weed Co. Gold Flora’s Net Loss Grows In Q4, Reports YoY Increase In Revenue & Gross Profit

Vertically-integrated California cannabis company Gold Flora Corporation announced on Friday its financial results for the three-month and twelve-month period ended Dec. 31, 2023. "We have strategically built a solid foundation consisting of premier indoor cultivation, and full vertical operations with deep consumer insights that have enabled our business to continue to expand its leadership position in California," Laurie Holcomb, CEO of Gold Flora, said. "This platform, combined with our focus on high-quality, profitable revenue streams has allowed us to capture more margin across every step of the supply chain and, as a result, we achieved positive adjusted EBITDA in the quarter, and improved our adjusted gross margin to approximately 66%, ahead of some of the leading multi-state operators in the industry.

GRAM